1 Einleitung - Universität zu Lübeck

82
74. Guarino AJ, Lee SP, Tulenko TN, Wrenn SP. Aggregation kinetics of low density
lipoproteins upon exposure to sphingomyelinase. J Colloid Interface Sci.
2004;279(1):109-16.
75. Guarino AJ, Tulenko TN, Wrenn SP. Sphingomyelinase-to-LDL molar ratio determines
low density lipoprotein aggregation size: biological significance. Chem Phys Lipids.
2006;142(1-2):33-42.
76. Glaros EN, Kim WS, Wu BJ, Suarna C, Quinn CM, Rye KA, Stocker R, Jessup W, Garner
B. Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is
associated with reduced plasma glycosphingolipid concentration. Biochem Pharmacol.
2007;73(9):1340-6.
77. Kolesnick RN. Sphingomyelin and derivates as cellular signals. Prog Lipid Res.
1991;30:1-38.
78. Chen H, Born E, Mathur SN, Field FJ. Cholesterol and sphingomyelin syntheses are
regulated independently in cultured human intestinal cells, CaCo-2: role of membrane
cholesterol and sphingomyelin content. J Lipid R. 1993;34:2159-67.
79. Merrill AH Jr, Jones DD. An update of the enzymology and regulation of sphingomyelin
metabolism. Biochim Biophys Acta. 1990;1044(1):1-12.
80. Svennerholm E, Ställberg-Stenhagen S, Svennerholm L. Fatty acid composition of
sphingomyelins in blood, spleen, placenta, liver, lung and kidney. Biochim Biophys Acta.
1966;125:60-9.
81. Nelson JC, Jiang XC, Tabas I, Tall A, Shea S. Plasma sphingomyelin and subclinical
atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol.
2006;163(10):903-12.
82. Auge N, Andrieu N, Negre-Salvayre A, Thiers JC, Levade T, Salvayre R. The
Sphingomyelin-ceramide signaling pathway is involved in oxidized low density
lipoprotein-induced cell proliferation. J Biol Chem. 1996;271(32):19251-5.
83. Schissel SL, Jiang X, Tweedie-Hardman J, et al.. Secretory sphingomyelinase, a product
of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH.
Implications for atherosclerotic lesions development. J Biol Chem. 1998;273(5):27383-46.
84. Takeichi S, Yukawa N, Nakajima Y. Association of plasma triglyceride-rich lipoprotein
remnants with coronary atherosclerosis in cases of sudden cardiac death.
Atherosclerosis. 1999;142(2):309-15.